CURE - Oncology & Cancer News for Patients & Caregivers
CURE - Oncology & Cancer News for Patients & Caregivers
Spotlight
BlogsCancer HorizonsClinical Trial CornerCURE's 20th Anniversary CelebrationPublicationsRecipesVideos
Cancer Type
View MoreBladderBreastCLLKidneyLungMCLOvarianProstateSkin
About CURE
Press ReleasesShare Your StoryWrite for CURE
News
Cancer Horizons
All News
Blogs
Caregiving
Diet and Exercise
Financial
Psychosocial
Recipes
Sexual Health
Side Effect
Sponsored
Survivorship
Videos
All Videos
CURE Connections
CURE Expert Connections
CURE Speaking Out
CURE TV
On Demand: Award Programs
On Demand: Patient Summits
On Demand: Webinars
Conferences
Conference Coverage
Conference Listing
Events
CURE Adventures
Award Programs
Educated Patient Summits
Educated Patient Webinars
Resources
Advocacy Groups
Art Gallery
Clinical Trial Corner
CURE Ambassador Program
Educated Patient Research Updates
Interactive Tools
Journey
Partners
Podcasts
Publications
Share Your Story
Subscribe
CURE Magazine
HEAL Magazine
Sign Up for eNews
  • About
  • Advertise / Support
  • Contact
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information

© 2023 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.

Cancer Type
Cancer Type
Bladder | Breast | CLL | Kidney | Lung | MCL | Ovarian | Prostate | Skin
View All >>
Spotlight
Spotlight
Blogs | Cancer Horizons | Clinical Trial Corner | CURE's 20th Anniversary Celebration | Publications | Recipes | Videos
Advertisement

Latest News

View All >>

Adjuvant Chemoradiotherapy Demonstrated Better Outcomes for Patients With Endometrial Cancer

January 29th 2023

By Colleen Moretti

Chemoradiotherapy may be an appropriate treatment option after surgery for patients with stage 3 endometrial cancer, especially those are a higher risk of recurrence.

As Rare Disease Day Approaches, I’m Reflecting on My MPN Diagnosis

January 28th 2023

By Wendy Reichental

I was shocked when I was diagnosed with a myeloproliferative neoplasm, and have dedicated myself to learning about the disease since.

First Patient Injected With Novel Radiotherapy in Phase 2b Trial for Brain Cancer

January 28th 2023

By Colleen Moretti

The treatment previously demonstrated significantly improved overall survival for patients with recurrent glioblastoma in a phase 1 study.

FDA Approves Orserdu for Some Patients with Metastatic Breast Cancer

January 27th 2023

By Colleen Moretti

The Food and Drug Administration approved Orserdu for patients with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer.

FDA Approves Jaypirca for Relapsed/Refractory Mantle Cell Lymphoma

January 27th 2023

By Brielle Benyon

The Food and Drug Administration approved Jaypirca for patients with relapsed/refractory mantle cell lymphoma who have been previously treated with multiple lines of therapy.

Blogs

View All >>

The Day I Realized My Oncologist Was a Real Person

January 27, 2023 6:00 PM

By Bonnie Annis

'Cancer Ghosting' Is an Unfortunate Reality

January 26, 2023 6:00 PM

By Natasha Carlson

Finding Our Purpose After Cancer

January 25, 2023 6:00 PM

By William Ramshaw

A Small, Inspiring Bushy-Tailed Visitor as a Distraction From Cancer

January 24, 2023 6:00 PM

By Mark Hicks

Publications

View All >>

Avoiding Unavoidable Carcinogens

January 4, 2023 4:00 PM

The Cancerous Legacy of Environmental Toxins

December 30, 2022 8:00 PM

Cholangiocarcinoma: New Hope for a Rare and Aggressive Cancer

December 30, 2022 2:00 PM

Genetic Targets Open the Door to New Treatment Options in Kidney Cancer

December 29, 2022 8:00 PM

Video Series

View All >>
MF Progression to Acute Myeloid Leukemia and Subsequent Treatment
Myelofibrosis: Novel Treatment Strategies and Combination Therapies
Novel Treatment Strategies in Essential Thrombocythemia and Polycythemia Vera
Adverse Events Tied to Treatment for Myeloproliferative Neoplasms
Healthcare Team Members Involved in Treating Myeloproliferative Neoplasms
Overview of Treatment Options for Myelofibrosis
Overview on the Management of Essential Thrombocythemia and Polycythemia Vera
Educated Patient® MPN Summit Myelofibrosis Panel: November 19, 2022
Educated Patient® MPN Summit Myelofibrosis Second-Line Treatment and Beyond Presentation: November 19, 2022
Educated Patient® MPN Summit First-line Treatment in Myelofibrosis Presentation: November 19, 2022
How Are Myeloproliferative Neoplasms Diagnosed?
A Background on Myeloproliferative Neoplasms
Educated Patient® MPN Summit Polycythemia Vera Panel: November 19, 2022
Educated Patient® MPN Summit Future Treatment of Polycythemia Vera Presentation: November 19, 2022
Educated Patient® MPN Summit Current Treatment Options in Polycythemia Vera Presentation: November 19, 2022
Podcasts
View All >>
Creating an Advocacy Group at the Onset of a Global Pandemic: KRAS Kickers Founder Shares Her Story
Childhood Cancer Survivor Pays It Forward at the Same Hospital She Received Treatment
Welireg Made a von Hippel-Lindau Survivor Feel Like a 'Medical Miracle'
Creating a Charity 8 Days After a Rare Cancer Diagnosis: Dying Defiantly Founder Shares His Story
A Nurse and Parent Explains Navigating Pediatric Oncology During COVID-19
From a 15-Month Prognosis to 17 Years of Survivorship: Heather Von St. James' Mesothelioma Story
Writing a Book Helped a Survivor Process Fears of Cancer Recurrence
From Volunteer to Patient to Advocate: How a Breast Cancer Survivor’s Life Has Changed Over the Years
Reading the Fine Print: How a Footnote on a CT Scan Led to an Unexpected Lung Cancer Diagnosis
Patient With Lung Cancer ‘Stays One Step Ahead’ of His Rare Mutation

Share Your Story

View All >>

As Rare Disease Day Approaches, I’m Reflecting on My MPN Diagnosis

January 28, 2023 7:00 PM

By Wendy Reichental

Is There a Scale for Cancer Survivorship?

January 26, 2023 2:00 PM

By Stephanie Landon

Cancer Is Like a Race, and I’m Determined to Win

January 25, 2023 4:00 PM

By Shoba Rao

Wondering ‘Why Me’ After a Cancer Diagnosis

January 23, 2023 8:00 PM

By John Smelcer, PhD, CAGS

Advertisement
  Advocacy Group Content

Advocacy Group Content

A Second Opinion Saved My Life!

Strategies for Managing Pain Associated with Pancreatic Cancer

Taking Chances to Beat Pancreatic Cancer

Putting Familial Risk In Perspective

View More Advocacy Group Content
Advertisement
  • About
  • Advertise / Support
  • Contact
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Write
  • Press Release
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com

© 2023 MJH Life Sciences™ and CureToday. All rights reserved.